-

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Applied Materials, Inc. (AMAT) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Applied Materials, Inc. (“Applied Materials” or the “Company”) (NASDAQ: AMAT) investors concerning the Company’s possible violations of federal securities laws.

On November 16, 2023, Reuters reported that Applied Materials was under criminal investigation by the U.S. Justice Department for potentially evading export restrictions on China’s top chipmaker SMIC.

On this news, Applied Materials’ stock price fell $6.19, or 4%, to close at $147.75 per share on November 17, 2023, thereby injuring investors.

Then, on February 27, 2024, Reuters reported that Applied Materials had received one subpoena from the Securities and Exchange Commission and another from the U.S. Attorney’s Office for the District of Massachusetts related to China shipments and requesting information related to certain federal award applications.

On this news, Applied Materials’ stock price fell $5.31, or 2.6%, to close at $197. 28 per share on February 27, 2024, thereby injuring investors further.

If you purchased Applied Materials securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:AMAT

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Encourages Alphabet Inc. (GOOGL) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOGL) common stock between May 19, 2026 and July 16, 2026, inclusive (the “Class Period”). Alphabet Inc. investors have until December 1, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALPHABET INC. (GOOGL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PAR...

Law Offices of Howard G. Smith Announces Investigation of Primoris Services Corporation (PRIM) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of acquired Primoris Services Corporation ("Primoris" or the "Company") (NYSE: PRIM) concerning whether the board breached its fiduciary duties to shareholders.IF YOU ARE A PRIMORIS SERVICES CORPORATION. (PRIM) SHAREHOLDER, CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE.On June 22, 2026, Primoris revealed a series of business updates including th...

Law Offices of Howard G. Smith Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) common stock between November 26, 2025 and August 28, 2026, inclusive (the “Class Period”). Anavex Life Sciences Corp. investors have until November 30, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ANAVEX LIFE SCIENCES CORP. (AVXL), CONTAC...
Back to Newsroom